TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD

por Ulf Mueller-Ladner, Hendrik Schulze-Koops, Tim Schmeiser, Hanns-Martin Lorenz, Christof Specker, Reinhard E Voll, Bimba F Hoyer, Jutta Richter, Alexander Pfeil, Rebecca Hasseli, Andreas Krause, Anne Constanze Regierer, Martin Schäfer
Publicado 2021